To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
38 Current news of Evonikrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
Evonik acquires Transferra Nanosciences Inc.
Evonik and Transferra Nanosciences, Inc., formerly known as Northern Lipids Inc., have signed an asset purchase agreement on June 21st, 2016 to acquire the business and assets of Transferra Nanosciences Inc., a biotechnology company based in Burnaby close to Vancouver (Canada). Both parties have ...
A significant advance in medical implant technology
Evonik is conducting cutting-edge research into biodegradable high-strength composites. These materials could potentially replace metal in implants used for the internal fixation of fractured bones. Implants play a key role in supporting bones until they heal. Today’s metallic devices typically ...
Evonik is commercializing biosurfactants: the specialty chemicals company is now the first in the world to use biotech methods for producing industrial-scale quantities of high- quality surfactants—key components of modern shampoos, shower gels, and household cleansers. The achievement has been ...
Evonik researchers and scientists at Graz University discover biotechnology access to 1-alkenes
Researchers at the specialty chemicals company Evonik Industries, in cooperation with scientists at Graz University, have discovered a biocatalytic access to 1-alkenes such as propene and 1-butene. Such hydrocarbon compounds are considered as key substances for the chemical industry's ...
Evonik has for the first time acquired shares in a young technology company in Germany via its venture capital arm. The Group invested in JeNaCell GmbH and now holds a minority share in the spin-off of Friedrich Schiller University in Jena. JeNaCell is a specialist for nanocellulose generated ...
Using creativity and unconventional ideas, researchers and engineers at Evonik have achieved a significant breakthrough in the biotechnological production of amino acids based on fermentation. They integrated the separating methods of chromatography and reverse osmosis and an online analytical ...
Evonik Industries is investing in the technology startup Algal Scientific Corporation (Northville, Michigan, USA). Evonik is part of an investors’ consortium that is investing more than US$3 million in Series A financing round. Under the trade name AlgamuneTM Algal markets 1,3-β-glucan, a ...
A milestone for third-generation biotechnology
For the first time, Evonik Industries has managed to use biotech methods to convert syngas to pure 2-hydroxyisobutyric acid (2-HIBA) under industrial conditions. 2-HIBA is a precursor used in the manufacture of PLEXIGLAS®. Waste gas is one example of a source of syngas. "We have shown that there ...
OPX Biotechnologies, Inc. (OPXBIO) and Evonik Industries AG announced the two companies have entered into an agreement to jointly develop certain bio-based specialty chemicals. The joint-development agreement signed May 3rd 2013 calls for OPXBIO to use its proprietary EDGE™ (Efficiency Directed ...
Patrik Wohlhauser, member of the Executive Board: “In the Health & Nutrition Business Unit alone we hope to see sales of €1 billion by 2020 from products made using biotechnology.”
Evonik Industries plans to continue expanding its commitment to biotechnology. “Biotech opens up interesting opportunities for profitable growth in a range of business areas,” says Patrik Wohlhauser, a member of the Executive Board. “It’s also giving Evonik’s growth strategy a stronger focus on ...